Effort to repeal 2.3% device tax will continue, AdvaMed says

01/3/2013 | MassDevice.com (Boston)

The 2.3% medical device tax has taken effect after Congress reached a deal to prevent the "fiscal cliff" on Tuesday. The industry, however, has vowed to continue the push to repeal the levy, which AdvaMed President and CEO Stephen Ubl said has bipartisan support "premised on the recognition that the tax is costing jobs and threatening patient care."

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI